T1	Outcomes 694 759	natural killer and lymphokine-activated killer cell cytotoxicity,
T2	Outcomes 843 860	T-cell activation
T3	Outcomes 903 924	rebound lymphocytosis
T4	Outcomes 929 1022	upregulation of the subset markers CD25 (interleukin 2 receptor) and CD45RO (T-memory cells).